Literature DB >> 15166746

Diagnosis of malignant ascites in prostate cancer by measurement of prostate specific antigen.

Vasu Appalaneni1, Sujatha Yellinedi, Michael A Baumann.   

Abstract

We were confronted with a case of ascites in a man with known cirrhosis and advanced prostate cancer. Initial studies of ascitic fluid suggested cirrhosis as the cause of ascites. However, a prostate-specific antigen (PSA) study of ascitic fluid strongly suggested that the ascites was caused by prostate cancer. Subsequent cytologic studies confirmed malignant ascites. We suggest that measurement of PSA may be a valuable adjunctive study for the diagnosis of malignant effusions in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166746     DOI: 10.1097/00000441-200405000-00024

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Malignant Ascites due to Prostatic Adenocarcinoma: An Extremely Rare Manifestation of a Common Disease.

Authors:  Stamatis S Papadatos; George Bazoukis; Georgios Deligiannis; Stefanos Mylonas; Christos Zissis
Journal:  J Clin Diagn Res       Date:  2016-11-01

2.  Malignant Ascites Associated with Carcinoma of the Prostate.

Authors:  Muhammad Wasif Saif
Journal:  J Appl Res       Date:  2005-01-01

3.  Metastatic prostate cancer with malignant ascites: A case report and literature review.

Authors:  Ifeanyi Ani; Mark Costaldi; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2013 Mar-Apr       Impact factor: 1.862

4.  Omental metastasis with malignant ascites: an unusual manifestation of prostatic adenocarcinoma.

Authors:  Sanjeev Madaan; Victor Palit; Patricia Gudgeon; Chandra Shekhar Biyani
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

5.  An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: Case report and literature review.

Authors:  Dimitrios Petrakis; George Pentheroudakis; Sevasti Kamina; Lambrini Pappa; Evangelos Papadiotis; Vassiliki Malamou-Mitsi; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2014-05-17       Impact factor: 10.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.